Distribution and Analysis of Metastatic Lymph Nodes in Colorectal Cancer Patients (DIAMOND)

Starting soon

Conditions studied: Colon Cancer, Rectal Cancer

In brief

The goal of this observational study is to learn about the spatial distribution and significance of metastatic lymph nodes in colorectal cancer patients. The main question it aims to answer is: * What is the spatial distribution pattern of metastatic lymph nodes in patients with colorectal cancer? * Can the spatial distribution pattern of metastatic lymph nodes in patients with colorectal cancer guide clinical practice? Participants should undergo regular follow-up examinations for at least 5 years after the surgery.

Key facts

Study ID

NCT07306390

Run by

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

People needed

1200

Starts

2026-07-01

Expected to finish

2028-01-31

Last updated by the study team

2026-06-09

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Aged between 18 and 80 years
• Pathologically confirmed adenocarcinoma of the colon or rectum
• Underwent radical resection for colorectal cancer with a D3 lymphadenectomy and lymph nodes were submitted for pathological examination according to standardized station-based and distance-based protocol
• No distant metastasis or distant metastasis within 6 months after surgery
• No history of other malignant tumors or severe systemic diseases
• No immune diseases or inflammatory bowel diseases
• Non-emergency surgery
• With complete clinicopathological and follow-up data

You may not qualify if…

• Pathologically confirmed benign tumors or non-adenocarcinoma malignancies
• Underwent local excision or palliative resection
• Regional lymph nodes were not dissected or submitted for pathological examination according to the unified station-based or distance-based protocol
• With distant metastasis or distant metastasis within 6 months after surgery
• Dual or multiple primary colorectal cancers or concurrent other malignant tumors
• Had a previous diagnosis of immune diseases or inflammatory bowel disease such as ulcerative colitis or Crohn's disease
• Underwent emergency surgery
• Had incomplete clinicopathological or follow-up data

Where it is running

• National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences — Beijing, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.